New Thought Police NewsGuard Is Owned by Big Pharma
STORY AT-A-GLANCE
- NewsGuard is a self-appointed internet watchdog that sells a browser plugin to rate websites on nine criteria of credibility and transparency
- NewsGuard received much of its startup funds from Publicis Groupe, a giant global communications group
- Publicis Groupe’s health subsidiary, Publicis Health, names Lilly, Abbot, Roche, Amgen, Genentech, Celgene, Gilead, Biogen, Astra Zeneca, Sanofi, Bayer and other Big Pharma giants as clients
- In October 2018, GlaxoSmithKline sent its $1.5 billion media account to Publicis
- In January 2020, GSK awarded Publicis Media with even more business, handing over the former Pfizer Consumer Healthcare Brands to Publicis, a move worth an estimated $400 million
- While NewsGuard’s warnings may be enough to prevent someone from clicking these links, I believe the true intent is to bury this content entirely from search results and social media feeds
The media is using a variety of tactics to restrict your access to the truth from websites like mine, including NewsGuard, a self-appointed internet watchdog that sells a browser plugin to rate websites on nine criteria of credibility and transparency. Before I delve further into NewsGuard and its underlying agenda, it’s important to look at who funds it.
NewsGuard received much of its startup funds from Publicis Groupe, a giant global communications group with divisions that brand imaging, design of digital business platforms, media relations and health care.
Publicis Groupe’s health subsidiary, Publicis Health, names Lilly, Abbot, Roche, Amgen, Genentech, Celgene, Gilead, Biogen, Astra Zeneca, Sanofi, Bayer and other Big Pharma giants as clients, which gives you an idea of where its loyalties lie.
GlaxoSmithKline (GSK) has also awarded Publicis Media a healthy piece of business, and the communications group responded by creating a custom “platformGSK” to run the drug giant’s media business.
…click on the above link to read the rest of the article…
